Wave Life Sciences Ltd.
DE ˙ DB ˙ SG9999014716
4,98 € ↑0,38 (8,26%)
2026-06-05
DEL PRIS
SecurityDE:1U5 / Wave Life Sciences Ltd.
InstitutionFmr Llc
Latest Disclosed Ownership5,192,761 shares
Ownership 2.80%
Fmr Llc ownership in 1U5 / Wave Life Sciences Ltd.

2026-05-06 - Fmr Llc has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 5,192,761 shares of Wave Life Sciences Ltd. (DE:1U5). This represents 2.8 percent ownership of the company. In their previous filing dated 2026-02-05 , Fmr Llc had reported owning 15,020,982 shares, indicating a decrease of -65.43 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date
Effective
Date
Form Prev
Shares
Latest
Shares
ΔShares
(Percent)
Ownership
(Percent)
ΔOwnership
(Percent)
2026-05-06 2026-05-06 13G/A 15,020,982 5,192,761 -65.43 2.80 -67.06
2026-02-05 2026-02-05 13G 1,108,649 15,020,982 1,254.89 8.50 113.09
2018-02-13 2018-02-13 13G/A 1,893,756 1,108,649 -41.46 3.99 -50.64
2017-02-14 2017-02-14 13G/A 2,057,632 1,893,756 -7.96 8.08 -17.78
2016-02-12 2016-02-12 13G 2,057,632 9.83

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F WAVE LIFE SCIENCES SHS Y95308105 5,192,761 -9,943,222 -65.69 37,648 -85.37 0.0004
2026-02-17 2025-12-31 13F WAVE LIFE SCIENCES SHS Y95308105 15,135,983 10,005,609 195.03 257,312 585.18 0.0131
2025-11-13 2025-09-30 13F WAVE LIFE SCIENCES SHS Y95308105 5,130,374 4,511,237 728.63 37,554 833.25 0.0020
2025-08-14 2025-06-30 13F WAVE LIFE SCIENCES SHS Y95308105 619,137 -1,525,690 -71.13 4,024 -76.78 0.0002
2025-05-12 2025-03-31 13F WAVE LIFE SCIENCES SHS Y95308105 2,144,827 317,107 17.35 17,330 -23.35 0.0011
2025-02-13 2024-12-31 13F WAVE LIFE SCIENCES SHS Y95308105 1,827,720 287,530 18.67 22,609 79.02 0.0013
2024-11-13 2024-09-30 13F WAVE LIFE SCIENCES SHS Y95308105 1,540,190 979,110 174.50 12,630 351.20 0.0008
2024-08-13 2024-06-30 13F WAVE LIFE SCIENCES SHS Y95308105 561,080 -607,693 -51.99 2,800 -61.18 0.0002
2024-05-13 2024-03-31 13F WAVE LIFE SCIENCES SHS Y95308105 1,168,773 -33,442 -2.78 7,211 18.78 0.0005
2024-02-13 2023-12-31 13F WAVE LIFE SCIENCES SHS Y95308105 1,202,215 541,790 82.04 6,071 59.89 0.0005
2023-11-13 2023-09-30 13F WAVE LIFE SCIENCES SHS Y95308105 660,425 -113,863 -14.71 3,797 34.74 0.0003
2023-08-11 2023-06-30 13F WAVE LIFE SCIENCES SHS Y95308105 774,288 -261,248 -25.23 2,818 -37.14 0.0002
2023-08-11 2023-03-31 13F/A-1 WAVE LIFE SCIENCES SHS Y95308105 1,035,536 -725,900 -41.21 4,484 -63.64 0.0004
2023-05-11 2023-03-31 13F WAVE LIFE SCIENCES SHS Y95308105 1,035,536 -725,900 4,484 0.0004
2023-02-13 2022-12-31 13F WAVE LIFE SCIENCES SHS Y95308105 1,761,436 -346,300 -16.43 12,330 62.04 0.0012
2022-11-10 2022-09-30 13F WAVE LIFE SCIENCES SHS Y95308105 2,107,736 869,710 70.25 7,609 89.09 0.0008
2022-08-12 2022-06-30 13F WAVE LIFE SCIENCES SHS Y95308105 1,238,026 1,171,432 1,759.07 4,024 2,925.56 0.0004
2022-05-13 2022-03-31 13F WAVE LIFE SCIENCES SHS Y95308105 66,594 66,594 133 0.0000
2021-05-14 2021-03-31 13F WAVE LIFE SCIENCES SHS Y95308105 0 -224,500 -100.00 0 -100.00
2021-02-08 2020-12-31 13F WAVE LIFE SCIENCES SHS Y95308105 224,500 -57,100 -20.28 1,767 -26.10 0.0002
2020-11-13 2020-09-30 13F WAVE LIFE SCIENCES SHS Y95308105 281,600 281,600 2,391 0.0002
2020-08-24 2020-06-30 13F/A-1 WAVE LIFE SCIENCES SHS Y95308105 0 -66,343 -100.00 0 -100.00
2020-05-14 2020-03-31 13F WAVE LIFE SCIENCES SHS Y95308105 66,343 -141,469 -68.08 622 -62.67 0.0001
2020-02-07 2019-12-31 13F WAVE LIFE SCIENCES SHS Y95308105 207,812 -116,600 -35.94 1,666 -74.98 0.0002
2019-11-13 2019-09-30 13F WAVE LIFE SCIENCES SHS Y95308105 324,412 -71,700 -18.10 6,660 -35.56 0.0008
2019-08-13 2019-06-30 13F WAVE LIFE SCIENCES SHS Y95308105 396,112 0 0.00 10,335 -32.84 0.0012
2019-05-13 2019-03-31 13F WAVE LIFE SCIENCES SHS Y95308105 396,112 -361,800 -47.74 15,389 -51.70 0.0018
2019-02-13 2018-12-31 13F WAVE LIFE SCIENCES SHS Y95308105 757,912 -100 -0.01 31,863 -15.93 0.0044
2018-11-09 2018-09-30 13F WAVE LIFE SCIENCES SHS Y95308105 758,012 -278,866 -26.89 37,901 -4.44 0.0043
2018-08-10 2018-06-30 13F WAVE LIFE SCIENCES SHS Y95308105 1,036,878 59,879 6.13 39,661 1.23 0.0047
2018-05-14 2018-03-31 13F WAVE LIFE SCIENCES SHS Y95308105 976,999 -131,650 -11.87 39,178 0.68 0.0047
2018-02-12 2017-12-31 13F WAVE LIFE SCIENCES SHS Y95308105 1,108,649 -405,200 -26.77 38,914 18.19 0.0046
2017-11-13 2017-09-30 13F WAVE LIFE SCIENCES SHS Y95308105 1,513,849 -115,200 -7.07 32,926 8.67 0.0040
2017-08-29 2017-06-30 13F/A-1 WAVE LIFE SCIENCES SHS Y95308105 1,629,049 -166,400 -9.27 30,300 -38.63 0.0038
2017-08-11 2017-06-30 13F WAVE LIFE SCIENCES SHS Y95308105 1,629,049 -166,400 30,300
2017-05-11 2017-03-31 13F WAVE LIFE SCIENCES SHS Y95308105 1,795,449 -98,307 -5.19 49,375 -0.30 0.0063
2017-02-10 2016-12-31 13F WAVE LIFE SCIENCES SHS Y95308105 1,893,756 31,907 1.71 49,522 -18.08 0.0066
2016-11-14 2016-09-30 13F WAVE LIFE SCIENCES SHS Y95308105 1,861,849 2,000 0.11 60,454 57.10 0.0081
2016-08-11 2016-06-30 13F WAVE LIFE SCIENCES SHS Y95308105 1,859,849 -112,289 -5.69 38,480 40.58 0.0053
2016-05-16 2016-03-31 13F WAVE LIFE SCIENCES SHS Y95308105 1,972,138 -85,494 -4.15 27,373 -16.59 0.0038
2016-02-12 2015-12-31 13F WAVE LIFE SCIENCES SHS Y95308105 2,057,632 2,057,632 32,819 0.0044
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.